Oncogeriatric development through time: the challenge of cancer - - PowerPoint PPT Presentation

oncogeriatric development through time the challenge of
SMART_READER_LITE
LIVE PREVIEW

Oncogeriatric development through time: the challenge of cancer - - PowerPoint PPT Presentation

Oncogeriatric development through time: the challenge of cancer care transformation " Matti Aapro, M.D. (Switzerland) Percentage of total population aged 60 years or older 2002 " Percentage'aged' 60'years'or'older''


slide-1
SLIDE 1


 Oncogeriatric development through time: the challenge of cancer care transformation
 
 "

Matti Aapro, M.D. (Switzerland)

slide-2
SLIDE 2

Percentage of total population aged 
 60 years or older 2002"

United'Na*ons.'Popula*on'Division.'Department'of'Economic'' and'Social'Affairs.'Popula*on'Ageing.'2002'

0–9' 10–19' 20–24' No'data' Percentage'aged' 60'years'or'older'' in'2002:'

slide-3
SLIDE 3

World Health Organization

Department of Chronic Diseases and Health Promotion

World Health Organization

WHERE ARE THE ELDERLY

  • R. Audisio EORTC EGAM 2007
slide-4
SLIDE 4

Mean age of global population is increasing

Figure taken from United Nations World Population Prospects at http://esa.un.org/unpp/index.asp?panel=2

55 50 45 40 35 30 25 20 15 Year United States South Korea Japan China India Mexico Pakistan 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 Median age (years)

slide-5
SLIDE 5

United'Na*ons.'Popula*on'Division.'Department'of'Economic'' and'Social'Affairs.'Popula*on'Ageing.'2050'

Percentage of total population aged 
 60 years or older 2050"

0–9' 10–19' 20–24' No'data' Percentage'aged' 60'years'or'older'' in'2050:'

slide-6
SLIDE 6

Are all older patients functionally the same?

received from R. Audisio

6

slide-7
SLIDE 7

Life expectancy in senior adults: a large variability reflecting health status variability

18 1 4.3 5.8 7.9 10.8 14.2 2.3 3.2 4.7 6.7 12.4 9.3 1.5 2.2 3.3 6.7 4.9

5 10 15 20 25

70 years 75 years 80 years 85 years 90 years 95 years Life expectancy, years Top 25th percentile (FIT seniors) Lowest 25th percentile (FRAIL seniors) 50th percentile (MEDIAN life expectancy)

Walter LC et al. JAMA 2001, 285, 2750-2756 Domains Cognition Comorbidity Emotional conditions Function Geriatric syndromes Nutrition Pharmacy Socioeconomic conditions

Health status groups

7

slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10

Short history of cancer treatment in older patients1

  • 1. Aapro M. J Geriatric Oncol 2010;1:2–3; 2. Fentiman IS, et al. Lancet 1990;335:1020–2
  • 3. Balducci L. NCCN Clinical Practice Guidelines in Oncology Senior Adult Oncology November 1, 2006
  • 4. Bokemeyer C, et al. Onkologie 2002;25:32–9
  • 5. Extermann M, et al. Crit Rev Oncol Hematol 2005;55:241–52

1983 1988 1990 1998 2000 2002 2003

National Cancer Institute and National Institute

  • n Ageing sponsor

a symposium Perspectives

  • n prevention

and treatment

  • f cancer in

the elderly

The Venice statement2 Cancer in the elderly: why so badly treated ?

First edition of Comprehensive Geriatric Oncology released International Society

  • f Geriatric

Oncology (SIOG) formed First onco- geriatric guidelines published

  • n the use
  • f haematopoietic

growth factors in elderly patients receiving cytotoxic chemotherapy3 World Health Organization 58th General Assembly resolution on Strengthening Active and Healthy Ageing Comprehensive Geriatric Assessment guidelines by the SIOG4 Dr BJ Kennedy encouraged the study of ageing and cancer during the Presidential Address at ASCO 1988

2005

US Geriatric Oncology Consortium founded to initiate trials and raise awareness

  • f problems
  • f elderly

patients

2006

National Comprehensive Cancer Network (NCCN) guidelines published practice guidelines for senior adult

  • ncology5

2010 JOURNAL

  • f GERIATRIC

ONCOLOGY ESMO HANDBOOK

slide-11
SLIDE 11

World Health Organization

Department of Chronic Diseases and Health Promotion

On May 2005 the 58th World Health Assembly adopted two resolutions:

  • Strengthening Active and Healthy Ageing
  • Cancer Prevention and Control

Following the adoption of these resolutions WHO is intensifying:

  • its global action against cancer
  • its action to develop the health care of older

persons.

slide-12
SLIDE 12

CANCER IS ON THE POLITICAL AGENDA

! The United Nations General Assembly adopted by

consensus the resolution titled "Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases" (document A/66/L.1). – High-Level Meeting on NCDs, 19-20 September 2011

slide-13
SLIDE 13
slide-14
SLIDE 14

UN Political Declaration

! We, Heads of State and Government and

representatives of States and Governments, assembled at the United Nations on 19 and 20 September 2011,…..

! 21. Recognize that the conditions in which people live

and their lifestyles influence their health and quality of life and that poverty, uneven distribution of wealth, lack of education, rapid urbanization, population ageing and the economic social, gender, political, behavioural and environmental determinants of health are among the contributing factors to the rising incidence and prevalence of noncommunicable diseases;

slide-15
SLIDE 15

UN Political Declaration

! Chapter 45 ! (e) Pursue and promote gender-based approaches for

the prevention and control of non-communicable diseases founded on data disaggregated by sex and age in an effort to address the critical differences in the risks of morbidity and mortality from non- communicable diseases for women and men;

slide-16
SLIDE 16

Growing interest has led to the formation

  • f a geriatric oncology society,

member of UICC

SIOG/ISGO

President: R. Audisio (UK) President-elect: A. Hurria (USA ) Past President: M. Extermann (USA) Treasurer: C. Steer ( AUS)

FNCLCC GEPOG GeriONNE GIOGer

EUGMS

EORTC

www.siog.org

slide-17
SLIDE 17
  • Arma senectutis artes

exercitationesque virtutum

  • The arms best adapted to old

age are culture and the active exercise of the virtues Cicero, De Senectute www.siog.org

slide-18
SLIDE 18

You may be sure, my dear Scipio and Laelius, that the arms best adapted to old age are culture and the active exercise of the

  • virtues. For if they have been maintained at

every period -if one has lived much as well as long- the harvest they produce is wonderful, not only because they never fail us even in our last days (though that in itself is supremely important), but also because the consciousness of a well-spent life and the recollection of many virtuous actions are exceedingly delightful.

WHY CICERO

Cicero, De Senectute

slide-19
SLIDE 19

We cannot simply apply principles of clinical studies validated in younger patients

EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors

A.G. Pallis, A. Ring, C. Fortpied, B. Penninckx, M.C. Van Nes, U. Wedding, G. von Minckwitz, C.D. Johnson,

  • L. Wyld, A. Timmer, F. Bonnetain, L. Repetto, M. Aapro, A. Luciani, H.Wildiers

On behalf of the EORTC Elderly Task Force Annals Oncology, 2011

slide-20
SLIDE 20

The SIOG guidelines

! Management of elderly patients with breast cancer:

updated recommendations of the International Society

  • f Geriatric Oncology (SIOG) and European Society of

Breast Cancer Specialists (EUSOMA).

Biganzoli L, Wildiers H, Oakman C, Marotti L, Loibl S, Kunkler I, Reed M, Ciatto S, Voogd AC, Brain E, Cutuli B, Terret C, Gosney M, Aapro M, Audisio R. Lancet Oncol 2012 Apr; 13:e148-60

! Anthracycline cardiotoxicity in the elderly

cancer patient: a SIOG expert position paper.

Aapro M, Bernard-Marty C, Brain EG, Batist G, Erdkamp F, Krzemieniecki K, Lenoard R, Lluch A, Monfardini S, Ryberg M, Soubeyran P, Wedding U. Ann

  • Oncol. 2011;22:257-67
slide-21
SLIDE 21

UICC World Cancer Declaration

slide-22
SLIDE 22

Martine Extermann, MD Moffitt Cancer Center Tampa, FL, USA

slide-23
SLIDE 23

SIOG/ISGO

2012 MEETING MANCHESTER, U.K. OCTOBER 25-27, 2012

www.siog.org

23